Diclofenac/misoprostol

Diclofenac/misoprostol, sold under the brand name Arthrotec, is a fixed-dose combination medication that contains:

Diclofenac/misoprostol
Combination of
DiclofenacNSAID
MisoprostolProstaglandin analog
Clinical data
Trade namesArthrotec
MedlinePlusa699002
License data
Pregnancy
category
  • Contraindicated
Routes of
administration		By mouth
ATC code
Legal status
Legal status
Identifiers
CAS Number
KEGG
  (verify)

In the United Kingdom it is marketed by Pharmacia and it is indicated for prophylaxis against NSAID-induced gastroduodenal ulceration in people requiring diclofenac for rheumatoid arthritis or osteoarthritis.[1]

The American College of Rheumatology and a Canadian consensus report both recommend GI-protective agents such as misoprostol be combined with long term NSAID therapy and a review concluded that diclofenac/misoprostol is a cost effective treatment in patients requiring long term NSAID therapy who are at increased risk of developing gastropathy.[3]

Contraindications

Arthrotec must not be taken during pregnancy, as it may deform or otherwise harm the fetus, or lead to miscarriage. This may be accompanied by potentially dangerous bleeding, possibly requiring surgery and potentially leading to infertility or death.[1]

References
  1. "Arthrotec 50 modified-release Tablets - Summary of Product Characteristics (SmPC)". (emc). 17 March 2021. Retrieved 3 August 2021.
  2. "Arthrotec- diclofenac sodium and misoprostol tablet, film coated". DailyMed. Retrieved 3 August 2021.
  3. Plosker GL, Lamb HM (July 1999). "Diclofenac/misoprostol. Pharmacoeconomic implications of therapy". PharmacoEconomics. 16 (1): 85–98. doi:10.2165/00019053-199916010-00008. PMID 10539124. S2CID 209146468.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.